03 December 2025
03 December 2025
Article doesn't exist
ATUM’s Leap-In platform enables AGC Biologics to offer various cell line development solutions for customers.
The partnership combines Citizen Health’s AI-based patient insights with UCB’s drug development expertise to improve outcomes.
Patient advocacy and industry bodies welcomed the bill’s backing, though it will now need to be passed in the Senate.
New non-primate draft guidance follows the agency’s wider aim to curtail the use of animal testing in preclinical toxicology.
As part of the 0% tariff deal, the NHS will pay 25% more for innovative medicines.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
